US Patent Issued to IMPERIAL COLLEGE INNOVATIONS, UNITED KINGDOM RESEARCH AND INNOVATION on July 28 for "NMT inhibitor treatment of a senescence-associated disease or disorder of the liver" (British Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,100, issued on July 28, was assigned to IMPERIAL COLLEGE INNOVATIONS Ltd. (London) and UNITED KINGDOM RESEARCH AND INNOVATION (Swindon, Great Britain).

"NMT inhibitor treatment of a senescence-associated disease or disorder of the liver" was invented by Edward Tate (London), Wouter Kallemeijn (London), Jesus Gil (London) and Domhnall McHugh (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method of prophylaxis or treatment of a senescence-associated disease or disorder by administering to a subject in need thereof, a therapeutically effective amount of a NMT inhibitor."

The patent was filed on May 4, 2022, und...